BMA
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Supports a bullish reading. Open-market purchases outweigh sales
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Financial indicators Supports a bullish reading. Current ratio 40.09 · operating margin 10%
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Unavailable or mixed. No stored price series
ACHAT TOTAL: 1500 titres (~102399 USD)
- Insiders
- Brito Marcos
- Total bought
-
$102,399
Avg buy (VWAP, 90d window) $68.27 vs last close —
- Total sold
-
—
Avg sell (VWAP, 90d window) —
- Last activity
- 2026-03-19
- Last synced
-
2026-09-18 10:15:07
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-03-19 | Brito Marcos | Buy | 1,500 | $68.27 | $102,399 | Form 4 |
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Market snapshot
Signal
Bearish signalScored 2026-09-18
BMA presents a deeply conflicted profile: a superficially high liquidity score (85) is entirely undermined by a likely accounting anomaly in current assets and critically low interest/debt service coverage ratios (0.26…
The first sentence of the analysis written for BMA on 2026-09-18 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 50.5% | 68.3% | 62.3% | 60.2% | 65.3% | |
| Ebit Margin | 10.2% | 5.6% | 19.4% | 7.5% | 8.6% | |
| Ebitda Margin | 11.8% | 7.7% | 20.7% | 8.4% | 11.1% | |
| Operating Profit Margin | 10.2% | 5.6% | 19.4% | 7.5% | 8.6% | |
| Pretax Profit Margin | 10.2% | 5.6% | 19.4% | 7.5% | 8.6% | |
| Continuous Operations Profit Margin | 5.8% | 5.1% | 13.1% | 5.1% | 8.2% | |
| Net Profit Margin | 5.8% | 5.0% | 13.1% | 5.1% | 8.2% | |
| Bottom Line Profit Margin | 5.8% | 5.0% | 14.8% | 5.1% | 8.2% | |
| Current Ratio | 40.093 | 0.505 | 0.569 | 0.390 | 0.401 | |
| Quick Ratio | 40.093 | 0.505 | 0.569 | 0.390 | 0.401 | |
| Solvency Ratio | 0.024 | 0.044 | 0.137 | 0.066 | 0.123 | |
| Cash Ratio | 40.093 | 0.327 | 0.361 | 0.193 | 0.292 | |
| Price To Earnings Ratio | 24.769 | 19.578 | 1.013 | 3.430 | 3.145 | |
| Price To Earnings Growth Ratio | 6.602 | -0.253 | 0.000 | 0.040 | -0.051 | |
| Forward Price To Earnings Growth Ratio | 6.602 | -0.253 | 0.000 | 0.040 | -0.051 | |
| Price To Earnings Diluted Ratio | 24.769 | 19.578 | 1.013 | 3.430 | 3.145 | |
| Price To Earnings Diluted Growth Ratio | 6.602 | -0.253 | 0.000 | 0.040 | -0.051 | |
| Price To Book Ratio | 1.599 | 1.574 | 0.327 | 0.116 | 0.197 | |
| Price To Sales Ratio | 1.439 | 0.986 | 0.150 | 0.035 | 0.054 | |
| Price To Free Cash Flow Ratio | 5,347.397 | 8.025 | -10.190 | 0.121 | 0.400 | |
| Price To Operating Cash Flow Ratio | 4,913.728 | 6.937 | -17.013 | 0.115 | 0.339 | |
| Debt To Assets Ratio | 0.066 | 0.032 | 0.063 | 0.037 | 0.046 | |
| Debt To Equity Ratio | 0.294 | 0.115 | 0.206 | 0.150 | 0.194 | |
| Debt To Capital Ratio | 0.227 | 0.103 | 0.171 | 0.130 | 0.162 | |
| Long Term Debt To Capital Ratio | 0.215 | 0.096 | 0.160 | 0.128 | 0.158 | |
| Financial Leverage Ratio | 4.443 | 3.579 | 3.296 | 4.081 | 4.171 | |
| Working Capital Turnover Ratio | -16.615 | -1.744 | -3.414 | -3.408 | -2.903 | |
| Operating Cash Flow Ratio | 0.019 | 0.108 | -0.011 | 0.400 | 0.236 | |
| Operating Cash Flow Sales Ratio | 0.000 | 0.142 | -0.009 | 0.300 | 0.160 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.919 | 0.864 | 1.670 | 0.953 | 0.846 | |
| Debt Service Coverage Ratio | 0.185 | 0.237 | 0.387 | 0.155 | 0.317 | |
| Interest Coverage Ratio | 0.265 | 0.185 | 0.530 | 0.192 | 0.254 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.019 | 48.457 | -1.658 | 0.000 | 4,766.314 | |
| Operating Cash Flow Coverage Ratio | 0.001 | 1.974 | -0.093 | 6.740 | 3.008 | |
| Capital Expenditure Coverage Ratio | 12.331 | 7.377 | -1.493 | 21.283 | 6.500 | |
| Dividend Paid And Capex Coverage Ratio | 0.005 | 1.553 | -1.489 | 11.923 | 6.500 | |
| Dividend Payout Ratio | 0.934 | 1.435 | 0.000 | 0.215 | 0.000 | |
| Enterprise Value Multiple | 9.164 | 8.154 | -0.164 | -0.789 | -0.810 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 50.5% | ▼-17.7% | ▼-10.8% |
| Ebit Margin | 10.2% | ▲4.7% | ▼-0.0% |
| Ebitda Margin | 11.8% | ▲4.1% | ▼-0.1% |
| Operating Profit Margin | 10.2% | ▲4.7% | ▼-0.0% |
| Pretax Profit Margin | 10.2% | ▲4.7% | ▼-0.0% |
| Continuous Operations Profit Margin | 5.8% | ▲0.8% | ▼-1.6% |
| Net Profit Margin | 5.8% | ▲0.8% | ▼-1.6% |
| Bottom Line Profit Margin | 5.8% | ▲0.8% | ▼-2.0% |
| Current Ratio | 40.093 | ▲39.588 | ▲31.701 |
| Quick Ratio | 40.093 | ▲39.588 | ▲31.701 |
| Solvency Ratio | 0.024 | ▼-0.021 | ▼-0.055 |
| Cash Ratio | 40.093 | ▲39.766 | ▲31.840 |
| Price To Earnings Ratio | 24.769 | ▲5.192 | ▲14.383 |
| Price To Earnings Growth Ratio | 6.602 | ▲6.855 | ▲5.334 |
| Forward Price To Earnings Growth Ratio | 6.602 | ▲6.855 | ▲5.334 |
| Price To Earnings Diluted Ratio | 24.769 | ▲5.192 | ▲14.383 |
| Price To Earnings Diluted Growth Ratio | 6.602 | ▲6.855 | ▲5.334 |
| Price To Book Ratio | 1.599 | ▲0.025 | ▲0.836 |
| Price To Sales Ratio | 1.438 | ▲0.453 | ▲0.906 |
| Price To Free Cash Flow Ratio | 5347.397 | ▲5339.372 | ▲4278.247 |
| Price To Operating Cash Flow Ratio | 4913.728 | ▲4906.791 | ▲3932.907 |
| Debt To Assets Ratio | 0.066 | ▲0.034 | ▲0.017 |
| Debt To Equity Ratio | 0.294 | ▲0.179 | ▲0.102 |
| Debt To Capital Ratio | 0.227 | ▲0.124 | ▲0.068 |
| Long Term Debt To Capital Ratio | 0.215 | ▲0.119 | ▲0.064 |
| Financial Leverage Ratio | 4.443 | ▲0.864 | ▲0.529 |
| Working Capital Turnover Ratio | -16.615 | ▼-14.871 | ▼-10.998 |
| Operating Cash Flow Ratio | 0.019 | ▼-0.089 | ▼-0.131 |
| Operating Cash Flow Sales Ratio | 0.000 | ▼-0.142 | ▼-0.118 |
| Free Cash Flow Operating Cash Flow Ratio | 0.919 | ▲0.054 | ▼-0.132 |
| Debt Service Coverage Ratio | 0.185 | ▼-0.052 | ▼-0.071 |
| Interest Coverage Ratio | 0.265 | ▲0.080 | ▼-0.021 |
| Short Term Operating Cash Flow Coverage Ratio | 0.019 | ▼-48.438 | ▼-962.607 |
| Operating Cash Flow Coverage Ratio | 0.001 | ▼-1.973 | ▼-2.325 |
| Capital Expenditure Coverage Ratio | 12.331 | ▲4.953 | ▲3.131 |
| Dividend Paid And Capex Coverage Ratio | 0.005 | ▼-1.548 | ▼-3.693 |
| Dividend Payout Ratio | 0.934 | ▼-0.500 | ▲0.417 |
| Enterprise Value Multiple | 9.164 | ▲1.010 | ▲6.053 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $8364.94B | $6372.57B | $1450.00B | $185.56B | $92.05B | |
| Enterprise value | $6313.55B | $4061.87B | -$329.89B | -$354.04B | -$153.29B | |
| EV / Sales | 1.09x | 0.63x | -0.03x | -0.07x | -0.09x | |
| EV / Op. cash flow | 3708.70x | 4.42x | 3.87x | -0.22x | -0.56x | |
| EV / Free cash flow | 4036.02x | 5.12x | 2.32x | -0.23x | -0.67x | |
| EV / EBITDA | 9.16x | 8.15x | -0.16x | -0.79x | -0.81x | |
| Net debt / EBITDA | -2.98x | -4.64x | -0.89x | -1.20x | -1.30x | |
| Current ratio | 40.09x | 0.51x | 0.57x | 0.39x | 0.40x | |
| Income quality | 0.01x | 7.11x | -87.67x | 67.06x | 1.86x | |
| Graham number | $10K | $9K | $18K | $5K | $2K | |
| Graham net-net | -$226K | -$101K | -$97K | -$58K | -$16K | |
| Tax burden | 56.6% | 90.4% | 67.3% | 68.9% | 95.1% | |
| Interest burden | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Working capital | $3497.95B | -$4197.91B | -$3214.71B | -$2463.70B | -$688.64B | |
| Invested capital | $187395.04B | -$3262.15B | -$2274.06B | -$2092.18B | -$569.28B | |
| Return on assets | 1.5% | 2.2% | 8.7% | 4.2% | 7.1% | |
| Operating ROA | 3.2% | 2.5% | 17.8% | 9.5% | 9.4% | |
| Return on tangible assets | -0.2% | 2.3% | 8.8% | 4.3% | 7.2% | |
| Return on equity | 6.4% | 8.0% | 28.6% | 17.3% | 29.7% | |
| Return on invested capital | 1.5% | 5.4% | 17.6% | 11.2% | 17.4% | |
| Return on capital employed | 2.6% | 6.0% | 26.3% | 16.2% | 18.3% | |
| Earnings yield | 4.0% | 5.1% | 87.4% | 149.0% | 150.7% | |
| Free cash flow yield | 0.0% | 12.5% | -9.8% | 828.0% | 249.8% | |
| Capex / Op. cash flow | 8.1% | 13.6% | -67.0% | 4.7% | 15.4% | |
| Capex / Depreciation | 0.0% | 90.1% | 87911.7% | 73.3% | 96.7% | |
| Capex / Sales | 0.0% | 1.9% | 0.6% | 1.4% | 2.5% | |
| SG&A / Sales | 27.2% | 15.7% | 9.5% | 6.5% | 20.6% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Intangibles / Total assets | 786.6% | 1.0% | 1.1% | 0.8% | 0.8% | |
| Days sales outstanding | 0d | 58d | 32d | 0d | 26d | |
| Days payables outstanding | 0d | 0d | 0d | 0d | 0d | |
| Operating cycle | 0d | 58d | 32d | 0d | 26d | |
| Cash conversion cycle | 0d | 58d | 32d | 0d | 26d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent news
- 2026-09-18 Engineers Gate Manager LP Makes New Investment in Macro Bank Inc. $BMA Engineers Gate Manager LP purchased a new position in shares of Macro Bank Inc. (NYSE: BMA) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 15,310 shares of the bank''s stock, valued at approximately $1,418,000. A number of other institutional investors have
- 2026-09-16 BMA vs. NABZY: Which Stock Should Value Investors Buy Now? Investors interested in stocks from the Banks - Foreign sector have probably already heard of Banco Macro (BMA) and National Australia Bank Ltd. (NABZY). But which of these two stocks is more attractive to value investors?
- 2026-09-16 Are Investors Undervaluing Macro Bank (BMA) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 2026-09-16 Banco Macro: Weaker Operating Momentum Makes Me More Cautious Banco Macro remains a quality Argentine banking play, but near-term risk-reward has deteriorated. Q2 2026 earnings beat expectations, with EPS of $1.92 versus $1.46 consensus and resilient net interest margins. BMA revised loan growth guidance sharply lower to 2-5% for 2026, citing subdued credit demand and rising delinquencies.
- 2026-09-14 Wall Street Analysts Predict a 44.99% Upside in Banco Macro (BMA): Here''s What You Should Know The consensus price target hints at a 45% upside potential for Banco Macro (BMA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- 2026-09-04 Best Growth Stocks to Buy for September 4th BMA, ATI, and OSCR it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 4, 2026.
- 2026-09-01 Best Growth Stocks to Buy for September 1st BMA, ATI, and SANM it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 1, 2026.
- 2026-08-31 BMA or NABZY: Which Is the Better Value Stock Right Now? Investors with an interest in Banks - Foreign stocks have likely encountered both Banco Macro (BMA) and National Australia Bank Ltd. (NABZY). But which of these two companies is the best option for those looking for undervalued stocks?
- 2026-08-31 Should Value Investors Buy Macro Bank (BMA) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 2026-08-27 Best Income Stocks to Buy for August 27th BMA, PROV and HMN made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 27th, 2026.